The Lymphoma Academic Research Organisation

This study tested a drug called glofitamab in 67 people with lymphoma that did not respond or came back after CAR T-cell therapy. The drug is a special antibody that helps the immune system attack cancer cells. The goal was to see if it could shrink tumors and help patients live …

This study tested whether a combination of two drugs, rituximab and lenalidomide, works better than the usual rituximab plus chemotherapy for people with untreated follicular lymphoma. About 1,000 patients took part. The goal was to see if the new combo could better control the d…

This study tested a drug called obinutuzumab added to standard chemotherapy and a stem cell transplant for people with mantle cell lymphoma, a rare blood cancer. 86 patients received the treatment and then maintenance therapy. The goal was to see if this approach could better con…

This study tested a new drug combination (pixantrone plus rituximab, ifosfamide, and etoposide) in 74 adults with aggressive non-Hodgkin lymphoma that had returned or not responded to previous treatments. The goal was to see how well the treatment shrank tumors after two cycles. …

This study tested an oral chemotherapy drug (azacitidine) against standard single-drug treatments for people with a rare type of blood cancer called angioimmunoblastic T-cell lymphoma that had returned or not responded to prior therapy. The goal was to see if the new pill could d…